CompletedNCT00590642
Acamprosate in treatment-resistant OCD
About this title
Read the official source — NCT00590642Observational studyAges 19–55United States
Understand this study
Who was this study for?
Listed age limits: 19 years to 55 years.
- Listed locations
- OmahaSee all locations and recruitment
Study information
Study start dateApril 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Creighton University
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 19 Years to 55 Years
- Official registry ID
- NCT00590642
- Official title
Show the full official title
Augment in Treatment-resistent Obsessive-compulsive Disorder: an Open-label Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Omaha
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Creighton University, a university.
Who was this study for?
Listed age limits: 19 years to 55 years.
